Supplemental Table 1 from Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma
Year: 2023
Type: supplementary-materials
Abstract: Supplemental Table 1 shows compounds that are pan-active in all three adrenocortical carcinoma cell lines (NCI-H295R, BD140A and SW-13).
Authors: Kei Satoh, Lisa Zhang, Yaqin Zhang, Raju Chelluri, Myriem Boufraqech, Naris Nilubol, Dhaval Patel, Min Shen, Electron Kebebew
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361970551